A randomised prospective comparison of intraperitoneal vancomycin plus aztreonam versus oral ofloxacin as primary treatment of bacterial peritonitis in CAPD patients
Dr Cheng, Ignatius Kum Po (Principal investigator)
Miss Wong (Co-Investigator)
Others - Medicine, Dentistry and Health
Other Funding Scheme
To investigate the relative efficacy and cost-benefit of using intraperitoneal vancomycin plus aztreonam versus oral ofloxacin as the primary mode of therapy in patients on continuous ambulatory peritoneal dialysis who develop bacterial peritonitis.